๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of glucocorticoids in the palliative treatment of metastatic brain tumors

โœ Scribed by Neil B. Ruderman; Thomas C. Hall


Publisher
John Wiley and Sons
Year
1965
Tongue
English
Weight
646 KB
Volume
18
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Whole brain radiotherapy in the treatmen
โœ Sandra S. Vermeulen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

Previous prospective and retrospective trials have failed to demonstrate the best treatment approach for patients with brain metastases. As a result, fractionated whole brain radiotherapy (WBRT) has been the mainstay of treatment for several decades. However, with improved surgical techniques and th

Surgical treatment of metastatic brain t
โœ Frederick F. Lang; Raymond Sawaya ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB ๐Ÿ‘ 2 views

Key elements in the modern surgical treatment of metastatic brain tumors are a firm grasp of criteria for selection of proper surgical candidates and a thorough grounding in the surgical approaches to, and the anatomy of, cerebral metastases. It is important to realize that the presence of multiple

Use of cutting balloon for palliative tr
โœ Karina M. Carlson; Steven R. Neish; Henri Justino; Glenn T. Leonard Jr; Charles ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 2 views

## Abstract In tetralogy of Fallot, severe cyanosis due to insufficient pulmonary blood flow necessitates early intervention. The Cutting Balloon, developed for percutaneous coronary angioplasty, was used successfully for transcatheter incision and dilation of infundibular and valvar pulmonary sten

VABโ€“4 combination chemotherapy in the tr
โœ Davor Vugrin; Esteban Cvitkovic; Willet F. Whitmore Jr.; Edgar Cheng; Robert B. ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 632 KB

Forty-two patients with advanced testis carcinoma without previous chemotherapy were treated with VAB-4, and 41 were evaluable. The program consisted of three in-hospital inductions 16 weeks apart, and outpatient treatments every three weeks. Of the patients, 80% achieved complete remissions (CR). C